ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,842Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 1290

$854K Total Retail Price of All Prescriptions

Rank: 68 out of 1290

805 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 805 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 805 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,278 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 486 405 1 4
SIMVASTATIN 472 453 2 1
AMLODIPINE BESYLATE 360 339 3 3
OMEPRAZOLE 293 245 4 2
FUROSEMIDE 274 233 5 9
HYDROCODONE-ACETAMINOPHEN 273 205 S3 6 6
LISINOPRIL 268 244 7 5
METOPROLOL TARTRATE 244 212 8 7
METFORMIN HCL 232 206 9 10
ZOLPIDEM TARTRATE 222 193 10 15
HYDROCHLOROTHIAZIDE 204 186 11 20
PRAVASTATIN SODIUM 179 146 12 42
SYNTHROID 170 145 13 28
LOVASTATIN 148 144 14 45
POTASSIUM CHLORIDE 140 118 15 35
TRAMADOL HCL 138 107 16 25
CRESTOR 124 114 17 17
LOSARTAN POTASSIUM 112 105 18 19
METOPROLOL SUCCINATE 111 89 19 14
ATENOLOL 105 99 20 18
MELOXICAM 103 83 21 31
ATORVASTATIN CALCIUM 102 94 22 23
TRIAMTERENE-HCTZ 93 85 23 130
ALLOPURINOL 88 72 24 60
NEXIUM 88 77 24 34
DIOVAN HCT 82 78 26 112
ENALAPRIL MALEATE 81 60 27 62
SERTRALINE HCL 77 70 28 36
LOSARTAN-HYDROCHLOROTHIAZIDE 76 72 29 106
GLYBURIDE 75 70 R 30 87
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 70 31 92
CARVEDILOL 73 69 31 12
GEMFIBROZIL 71 57 33 210
WARFARIN SODIUM 71 59 33 22
GABAPENTIN 68 49 35 8
GLIMEPIRIDE 63 62 36 57
AZITHROMYCIN 63 52 36 61
ADVAIR DISKUS 63 54 36 37
CITALOPRAM HBR 63 51 36 29
CLOPIDOGREL 62 57 40 24
PREDNISONE 61 49 41 21
ZETIA 61 49 41 165
DIGOXIN 61 61 41 51
TAMSULOSIN HCL 59 59 44 11
VERAPAMIL ER 58 57 45 259
PANTOPRAZOLE SODIUM 55 39 46 48
RANITIDINE HCL 53 41 47 49
FINASTERIDE 53 53 47 40
KLOR-CON M20 52 44 49 268
PROAIR HFA 52 31 49 73
TERAZOSIN HCL 51 51 51 157
RAMIPRIL 51 38 51 136
ISOSORBIDE MONONITRATE ER 51 50 51 58
GLIPIZIDE 51 47 51 81
CLONIDINE HCL 51 46 51 66
ALENDRONATE SODIUM 50 44 56 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.